QIAGEN N.V. Cash and Cash Equivalents
QIAGEN N.V. (QGEN) had Cash and Cash Equivalents of $839.00 million as of 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-03-20
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $839.00M.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $663.55M.
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value $668.08M.
- 2022-12-31: Cash and Cash Equivalents, at Carrying Value $730.67M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | $839.00M 20-F · filed 2026-03-20 |
| 2024-12-31 | $663.55M 20-F · filed 2026-03-20 |
| 2023-12-31 | $668.08M 20-F · filed 2025-03-31 |
| 2022-12-31 | $730.67M 20-F · filed 2024-03-11 |
| 2021-12-31 | $880.52M 20-F · filed 2023-03-13 |
| 2020-12-31 | $597.98M 20-F · filed 2022-03-14 |
| 2019-12-31 | $623.65M 20-F · filed 2021-03-05 |
| 2018-12-31 | $1.16B 20-F · filed 2020-03-02 |
| 2017-12-31 | $657.71M 20-F · filed 2019-03-06 |
| 2016-12-31 | $439.18M 20-F · filed 2019-03-06 |
| 2015-12-31 | $290.01M 20-F · filed 2019-03-06 |
| 2014-12-31 | $392.67M 20-F · filed 2018-03-06 |
| 2013-12-31 | $330.30M 20-F · filed 2017-03-06 |
| 2012-12-31 | $394.04M 20-F · filed 2016-02-29 |
| 2011-12-31 | $221.13M 20-F · filed 2015-03-02 |
| 2010-12-31 | $828.41M 20-F · filed 2014-03-03 |
| 2009-12-31 | $825.56M 20-F · filed 2013-03-04 |
| 2008-12-31 | $333.31M 20-F · filed 2012-03-27 |
| 2007-12-31 | $347.32M 20-F · filed 2011-03-21 |